Interferon epsilon and ovarian cancer.
interferon
interferon epsilon
ovarian cancer
tumor suppressor
type I interferon
Journal
Trends in cancer
ISSN: 2405-8025
Titre abrégé: Trends Cancer
Pays: United States
ID NLM: 101665956
Informations de publication
Date de publication:
Dec 2023
Dec 2023
Historique:
received:
18
09
2023
accepted:
21
09
2023
medline:
27
11
2023
pubmed:
2
10
2023
entrez:
1
10
2023
Statut:
ppublish
Résumé
Most biologists know of the interferons IFNα, IFNβ, and IFNγ and their roles in immunity and infection, but they may not have heard of IFNε. A recent study in Nature suggests that IFNε can act as a tumor suppressor in serous ovarian cancers.
Identifiants
pubmed: 37778961
pii: S2405-8033(23)00192-9
doi: 10.1016/j.trecan.2023.09.008
pii:
doi:
Substances chimiques
IFNE protein, human
0
Interferons
9008-11-1
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
985-986Informations de copyright
Copyright © 2023 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of interests F.R.B. is on the Scientific Advisory Board of iOmx Therapeutics, Stromacare. F.R.B. receives Honorarium from GSK.